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ABSTRACT: Purpose: To study the laboratory predicted anticaries efficacy of five commercially available fluoride 
varnishes (FV) by determining their ability to reharden and to deliver fluoride to an early caries lesion when applied 
directly or in close vicinity to the lesion (halo effect). Methods: Early caries lesions were created in 80 polished bovine 
enamel specimens. Specimens were allocated to five FV groups (n=16) based on Knoop surface microhardness (KHN) 
after lesion creation. All tested FV claimed to contain 5% sodium fluoride and were: CavityShield, Enamel Pro, MI 
Varnish, Prevident and Vanish. FV were applied (10 ± 2 mg per lesion) to eight specimens per FV group (direct 
application); the remaining eight specimens received no FV but were later exposed to fluoride released from specimens 
which received a FV treatment (indirect application). Specimens were paired again and placed into containers (one per 
FV). Artificial saliva was added and containers placed into an incubator (27 hours at 37°C). Subsequently, FV was 
carefully removed using chloroform. Specimens were exposed to fresh artificial saliva again (67 hours at 37°C). KHN 
was measured and differences to baseline values calculated. Enamel fluoride uptake (EFU) was determined using the 
acid etch technique. Data were analyzed using two-way ANOVA. Results: The two-way ANOVA highlighted 
significant interactions between FV vs. application mode, for both ΔKHN and EFU (P< 0.001). All FV were able to 
reharden and deliver fluoride to caries lesions, but to different degrees. Furthermore, considerable differences were 
found for both variables between FV when applied either directly or in close vicinity to the lesion: MI Varnish and 
Enamel Pro exhibited greater fluoride efficacy when applied in vicinity rather than directly to the lesion, whereas 
CavityShield and Vanish did not differ. Prevident exhibited a higher EFU when applied directly, but little difference in 
rehardening. (Am J Dent 2013;26:000-000). 
CLINICAL SIGNIFICANCE: The present laboratory study showed that commercially available fluoride varnishes vary 
considerably in their ability and mechanism to deliver fluoride to enamel for the prevention of dental caries. 
: Frank Lippert, Department of Preventive and Community Dentistry, Oral Health Research Institute, Indiana 
University School of Dentistry, 415 Lansing Street, Indianapolis, IN 46202, USA. E-: flippert@iupui.edu 
Introduction 
 In 1964, Schmidt1 developed the first fluoride varnish 
(FV) to prolong the contact time of sodium fluoride with the 
tooth surface as fluoride is cleared rather rapidly from the 
oral cavity, thereby shortening its ability to interact with the 
target tissues. FV are relatively simplistic delivery vehicles 
for cariostatic amounts of fluoride and typically contain 5% 
sodium fluoride, beeswax or white wax and ethanol or ethyl 
acetate as organic solvents, to form a gel-type structure to 
stabilize sodium ions; shellac and mastic, to provide a 
flexible, permeable hard surface that prevents the varnish 
from dissolving rapidly in saliva; a flow enhancer, such as 
colophonium, as well as sweeteners, such as xylitol or 
sodium saccharin, and flavor compounds.2 Essentially, FV 
are non-aqueous suspensions of sodium fluoride which are 
painted onto all accessible ‘toothbrush-clean’ tooth surfaces 
where they remain for several hours until they are abraded by 
food, through mastication, intra-oral friction with the tongue 
and soft tissues, or simply flake off. During their contact 
hours, FV will not only release fluoride to the tooth surface 
but also into saliva. Fluoride can then migrate to areas not 
covered by FV during the application phase (e.g. 
interproximal) and interact with these surfaces. 
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 A previous study3 highlighted no differences in the in 
vitro remineralization efficacy when FV was applied over vs. 
around the lesion. However, this study was limited to only 
one commercially available FV. In recent years, at least 32 
different FV (based on a personal review of fluoride 
varnishes available through distributors of dental 
professional products in the USA) are commercially 
available in the United States, compared to only three in 
2000.4 Some contain added ingredients, such as casein 
phosphopeptide-amorphous calcium phosphate (CPP-ACP), 
ACP, tri-calcium phosphate or xylitol, which have been 
shown to enhance anticaries efficacy,5-8 although not yet in a 
varnish delivery format. Apart from two FV, Duraphata and 
Fluor Protector,b,9 none of the currently commercially 
available FV have been clinically tested for their ability to 
prevent caries, and the majority has not been tested under 
laboratory conditions either, highlighting a clear need for 
further research to establish suitable testing guidelines for 
their efficacy. 
 In contrast to other fluoride delivery formats, 
comparative studies on different FV are relatively sparse and 
have typically only focused on fluoride release from FV into 
a surrounding medium.10-14 Enamel fluoride uptake15-18 and 
remineralization studies,3,19,20 have been conducted, but not 
in combination and while focusing only on few FV. 
Furthermore, mechanistic studies on fluoride delivery as a 
function of application mode have not been conducted yet. 
 Therefore, the present study investigated the in vitro 
anticaries efficacy of five commercially available FV. The 
null hypothesis tested was that FV did not differ in their 
ability to reharden and to deliver fluoride to an early caries 
lesion when applied directly or in close vicinity to the lesion 
(so-called ‘halo effect’).  
Materials and Methods  
Specimen preparation - Enamel specimens were obtained 
from approximately 150 bovine incisors, with one specimen 
being prepared per tooth. Tooth crowns were cut into 4 × 4 
mm specimens using a low-speed saw (Isometc). The teeth 
were stored in deionized water saturated with thymol during 
the sample preparation process. Specimens were ground and 
polished to create flat, planar parallel dentin and enamel 
surfaces using a Struers Rotopol 31/Rotoforce 4d polishing 
unit. The dentin side of the specimens was ground flat to a 
uniform thickness with 500-grit silicon carbide grinding 
paper. The enamel side of the specimen was serially ground 
using 1,200, 2,400 and 4,000 grit paper. The specimens were 
then polished using a 1 µm diamond polishing suspension on 
a polishing cloth. Resulting specimens had a thickness range 
of 1.7 – 2.2 mm. The specimens were assessed under a Nikon 
SMZ 1500e stereomicroscope at ×20 magnification for 
cracks, hypomineralized (white spots) areas or other flaws in 
the enamel surface that would exclude them from use in the 
study. Prepared specimens were stored at 4°C (walk-in 
refrigerator) and 100% relative humidity (closed container 
containing excess deionized water saturated with thymol, 
specimens stored enamel facing upwards) until use. Sixteen 
specimens per FV treatment group were used for this study. 
Specimens were individually mounted onto a 1-inch square 
acrylic block using sticky wax to facilitate surface 
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microhardness measurements. Specimens remained on their 
blocks for the entire study period.  
Lesion formation - Artificial caries lesions were formed in 
the enamel specimens using a modification of the method 
described by White.21 Specimens were immersed into a 
solution of 0.05 M lactic acid and 0.2% Carbopol C907 
which was 50% saturated with hydroxyapatite and adjusted 
to pH 5.0. Initial demineralization was performed at 37°C for 
24 hours and at a ratio of 40 ml solution per specimen. 
Specimens were then rinsed with deionized water and stored 
at 4°C and approximately 100% relative humidity until 
further use.  
Lesion baseline characterization - Initial hardness of the 
demineralized specimens was determined using a Knoop 
microhardness indenter (Wilson 2100 Hardness Testere) at a 
load of 50 g for 11 seconds. The Knoop surface 
microhardness test was chosen ahead of other specimen 
interrogation techniques for various reasons. It is inherently 
less prone to variability and has offered greater sensitivity 
than the current “gold standard” technique, transverse micro-
radiography, when studying de- and remineralization of early 
caries lesions similar to those studied presently.22 
 The average specimen surface microhardness (KHNbase) 
was determined from five indentations, spaced 100 μm apart 
in the center of each specimen. Only specimens with a mean 
KHNbase between 17 and 32 were accepted to minimize 
variability and to allow for potential treatment effects to be 
observed. Specimens were then assigned to groups and 
subgroups following a stratified randomization procedure, 
based on their KHNbase. 
 Sound enamel hardness measurements were performed in 
the present study (only specimens with 336 < KHNsound < 445 
were accepted). As these data were not needed in the 
calculation of rehardening efficiency, these are merely 
reported for completeness.  
Test products - A total of five fluoride varnishes were tested 
in the present study (Table 1). FV were chosen with the aim 
to include FV with different added ingredients and those 
from the most prominent manufacturers of professional 
dental products. A fluoride-free placebo varnish was not 
included as these are not commercially available. Fluoride 
content of FV was not investigated as no reliable method for 
the analysis of total fluoride content has been reported yet. A 
method that was proposed recently23 was later24 found to be 
inadequate for FV containing calcium compounds, such as 
several of those currently marketed.  
Fluoride varnish application - All FV showed signs of phase 
separation which was expected given their composition. FV 
were applied according to manufacturers’ instructions and 
using the supplied microbrushes. All FV were supplied in 
single unit doses and were first homogenized after removal 
of the foil covering by stirring the FV for at least 10 seconds 
using said brush. Any material adhering to the inside of the 
foil covering was removed using the microbrush and added 
to the bulk varnish. Immediately after homogenization, 
approximately 10 ± 2 mg of FV were applied to each of eight 
specimens per FV treatment group (direct application). The 
remaining eight specimens did not receive a direct FV 
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application but were exposed to fluoride released from the 
specimens which did receive a FV treatment and thus 
received an indirect application. The time required to apply 
the FV was approximately 5 minutes per treatment group.  
Lesion rehardening - Immediately after FV application, all 
16 specimens per FV treatment group were placed into an 
airtight container (square-shaped, 1.1 l volume), FV-treated 
and untreated specimens side-by-side and in alternating order 
(four rows of four acrylic blocks with one specimen per 
block). Then, 200 ml of artificial saliva (1.45 mM 
CaCl2×2H2O; 5.40 mM KH2PO4; 14.90 mM KCl; 28.40 mM 
NaCl; 2.20 g/l porcine gastric mucin, adjusted to pH 7.0 with 
KOH) was carefully poured into the container, avoiding 
direct contact with the FV-treated specimens, but submerging 
all specimens eventually. The container was then placed into 
an incubator set at 37°C for 27 hours. The artificial saliva 
was not replaced during that period. Subsequently, the 
artificial saliva was decanted and specimens and container 
rinsed with deionized water. The FV was now carefully 
removed using chloroform-moistened cotton swabs. An 
average of two swabs was required to remove the FV from 
the FV-treated specimens. Specimens were assessed for 
successful FV removal by eye (mirror-like appearance). 
Specimens not treated with FV were not cleaned. 
 All specimens were placed back into their containers and 
200 ml of fresh artificial saliva was added. The container was 
placed into the incubatork again but for 67 hours. The 
artificial saliva was not replaced during this period. After 
rehardening, specimens were rinsed with deionized water and 
stored at 4°C and 100% relative humidity until further use.  
Post-treatment lesion characterization - The mean KHNpost 
of each specimen was determined, as described above, from 
five indentations placed in close proximity to the lesion 
baseline indentations on the surface of each specimen. The 
change in KHN vs. lesion baseline was calculated as follows: 
ΔKHN = KHNpost - KHNbase.  
Enamel fluoride uptake - Each enamel specimen was acid-
etched using 0.5 ml of 1 M HClO4 for 15 seconds. 
Throughout this period, the acid-etch solution was 
continuously agitated using an up and down motion of the 
specimens. This was immediately followed by rinsing the 
specimens thoroughly with deionized water. A sample of 
each solution was then buffered with TISAB II (0.25 ml 
sample, 0.5 ml TISAB II and 0.25 ml 1 N NaOH) and the 
fluoride content determined by comparison to a similarly 
prepared standard curve (1 ml standard + 1 ml TISAB II). In 
order to calculate the amount of enamel removed by the 15-
second acid-etch procedure, the calcium content of the acid-
etch solution was determined by atomic absorption (0.05 ml 
sample, 1 ml 0.18 M LaCl3 and 3.95 ml deionized water). 
From these fluoride and calcium data, the fluoride 
concentration of each specimen was calculated and expressed 
as ppm. The fluoride content in the specimens before FV 
treatment was not evaluated as previous studies conducted in 
the present authors’ laboratories highlighted comparatively 
low values (< 50 ppm).  
Statistical analysis - The data were tested for normal 
distribution (Shapiro-Wilk test). The variables ΔKHN and 
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EFU were calculated for each specimen and analyzed using a 
two-way ANOVA with factors for ‘fluoride varnish’ and 
‘application mode (direct vs. indirect)’ and their interaction. 
ΔKHN was the primary variable. Where significant 
differences were indicated, the individual means were 
analyzed by the Fisher’s Least Significant Difference test. 
The significance level for the analyses was set at 5%. 
Correlation coefficient (Pearson) was calculated to evaluate 
the association between variables.  
Results  
 KHNbase were virtually identical between and within 
treatment groups (mean range 24-25). The two-way ANOVA 
highlighted significant interactions between fluoride varnish 
vs. application mode, for both ΔKHN and EFU (both P< 
0.001). The results and statistical analyses for both study 
variables can be found in Table 2. When comparing for 
ΔKHN and the direct application of FV onto the lesion, the 
FV’s efficacy decreased in the following order: Prevident, 
Vanish, CavityShield, Enamel Pro, MI Varnish. Almost 
opposite results were obtained for the indirect application of 
FV: MI Varnish, Enamel Pro, Prevident, CavityShield, 
Vanish. While the EFU matched the ΔKHN data well, there 
were several groups with opposing trends (Prevident, 
CavityShield). Overall, there was a moderate yet statistically 
significant correlation between ΔKHN and EFU (R = 0.34; 
P= 0.003).  
Discussion  
 The present study has showed that FV differ in their 
ability to reharden and to deliver fluoride to an early caries 
lesion when applied directly or in close vicinity to the lesion 
(Table 2). Therefore, the null hypothesis was rejected. 
 FV are approved by the Food and Drug Administration 
(FDA) in the United States as medical devices for the use as 
cavity liners or for the treatment of dentin hypersensitivity. 
Since their introduction in 1994, FV have, however, also 
been used ‘off-label’ by dental professionals as a topical 
fluoride agent for the prevention of caries. While the 
American Dental Association (ADA) Council on Scientific 
Affairs has concluded that “fluoride varnish applied every 6 
months is effective in preventing caries in the primary and 
permanent dentition of children and adolescents”,25 none of 
the FV sold in the United States are marketed as such. As 
caries prevention constitutes a drug claim, FV manufacturers 
would have to submit substantial scientific evidence (two 
clinical caries trials are required) for review by the FDA. 
This has created a grey area for manufacturers as unlike for 
over-the-counter oral care products, such as fluoride 
dentifrices and mouthwashes, no efficacy or safety testing is 
currently required for FV. This highlights a clear need to 
establish the anticaries efficacy of currently marketed FV. 
While a comparative clinical evaluation of several FV would 
appear most appropriate, the cost implications of such an 
undertaking are prohibitive. Therefore, laboratory studies are 
used first to determine the FV’s predicted anticaries efficacy 
and mode of action. 
 The present study showed that the tested, commercially 
available FV vary considerably in their ability and 
mechanism to deliver their active ingredient, sodium 
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fluoride, to early caries lesions. Furthermore, the tested FV 
exhibited significant differences in their ability to reharden 
these lesions. Especially the differences in fluoride delivery 
between FV – approximately two- and four-fold differences 
were observed depending on the application mode (Table 2) 
– give rise to concern. While there is still some debate in the 
literature as to the exact mode of action of FV, it seems 
logical to assume that the delivery of fluoride to the dental 
hard tissues rather than the release of fluoride into saliva is 
the primary mode of action of FV. FV application is rather 
infrequent (every 3-6 months); and while salivary fluoride 
concentrations are elevated after FV application, they do 
reach baseline levels again after approximately 24 hours.26 
Such short, infrequent periods of elevated fluoride 
concentrations in the oral cavity do not necessarily explain 
the rates in caries reduction observed in many clinical trials.9 
Thus, it seems all the more likely that fluoridation of 
incipient subclinical lesions is the primary mode of action. In 
fact, substantial increases in enamel fluoride content were 
observed in many clinical studies, not only shortly after a 
single FV application but also several weeks later.27-32 
 Fluoride can be taken up by enamel in various forms, 
which can be, albeit crudely, divided into loosely- (e.g. as 
calcium fluoride) and structurally-bound fluoride (e.g. as 
fluoridated hydroxyapatite). The former is the primary mode 
of fluoride uptake by enamel and dentin, acts as a labile 
reservoir of fluoride ions, and can serve as a source for the 
latter.34 Indeed, such observations were made after clinical 
FV application.16 Fluoride applied at high concentrations, 
such as from FV, will primarily form non-stoichiometric 
calcium fluoride,21 which is considerably more stable in situ 
than under laboratory conditions due to the protection by 
pellicle proteins.35 Thus, it is likely that in vitro 
investigations underestimate the anticaries efficacy of FV 
and especially when FV are compared to other fluoride 
delivery formats, which may explain the results of some 
previous studies.36,37 
 The purpose of added ingredients, such as those of the FV 
tested presently, can be questioned in light of the application 
frequency and mode of action of FV. Considering the direct 
application mode, the addition of CPP-ACP, ACP or tri-
calcium phosphate failed to enhance EFU and lesion 
rehardening compared to those FV containing xylitol (Table 
2). Inherent formulation differences may have overcome any 
potential benefits, but unless an added ingredient can directly 
enhance the delivery of fluoride to the dental hard tissues, its 
addition is questionable. In contrast, however, are the results 
of the indirect application mode which highlighted beneficial 
effects of the FV containing CPP-ACP or ACP. These can 
potentially be attributed to the added ingredients, although it 
is more likely that inherent formulation differences between 
FV, resulting in different fluoride release characteristics and 
interaction with the enamel surface, may have accounted for 
the present observations. Thus, the present results for both 
direct and indirect application modes can be best explained 
by (a) the ability of the FV to interact with the enamel 
surface and to deliver fluoride directly to the lesion, and (b) 
the ability of the FV to release fluoride into the surrounding 
medium to fluoridate inaccessible areas not covered by FV 
during the application phase. Ideally, FV should accomplish 
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both. However, this did not appear to be the case as, for 
example, MI Varnish was somewhat inferior in its direct 
interaction with the enamel surface, but was able to 
effectively release fluoride into saliva. Likewise, it could be 
argued that Vanish was inferior to all other tested FV due to 
its poor fluoride delivery in general. Consequently, one of the 
major findings of the present study was that FV are far more 
complex fluoride delivery vehicles which deserve 
considerably more attention from manufacturers and 
researchers alike. 
 Manufacturers of FV recommend painting all accessible 
tooth surfaces with FV, regardless of the presence of early or 
established caries lesions. The present study showed that, 
albeit its limitations (see below), three of the tested five FV 
differed greatly in their ability to deliver fluoride between 
direct and indirect application modes; however with no clear 
indication which mode would be favorable (Table 2). 
Previous clinical38 and in situ17 studies highlighted that 
fluoride migration is rather limited in the oral cavity and 
dependent on the particular FV being applied. However, both 
studies investigated Duraphat which has been shown in 
several studies11,13,39 to be inferior in its fluoride release into 
the surrounding medium compared to many other FV, 
including those investigated presently. The results of one 
recent study40 somewhat mirrored those of the indirect 
application mode (Table 2). It can therefore be speculated 
that FV exhibiting superior fluoride ion release may be able 
to effectively fluoridate more remote sites, although this 
would have to be confirmed in situ/in vivo. 
 Fluoride can contribute to lesion arrest through 
hypermineralization of the surface layer which would be a 
warranted side effect of a FV application. The indirect 
application mode is perhaps also a suitable way to determine 
FV efficacy for inaccessible areas, such as interproximal 
spaces. Unless the FV can migrate on its own into these 
spaces, fluoride released from FV will have to migrate there 
and effectively interact with these vulnerable surfaces. 
 Naturally, laboratory models are only surrogates for 
clinical caries by not completely mimicking every facet of 
the de- and remineralization processes. The present study is 
no exception as, (a) saliva was not continuously replenished 
which would occur clinically; (b) the FV/saliva ratio was 
lower than it would have been clinically; and (c) bovine 
enamel was used which was recently shown to exaggerate 
fluoride effects to some degree,40 to name only a few of the 
shortcomings which can, however, be applied to many other 
FV laboratory studies. Likewise, surface microhardness 
measurements do not allow for a complete understanding of 
mineral changes within caries lesions. Any rehardening 
observed in the present study may also be indicative of 
hypermineralization, although this could be considered a 
clinically meaningful outcome as it is representative of lesion 
arrest. Nonetheless, the results of the present study have to be 
seen with caution until they are confirmed clinically. 
Regardless, the observed differences in fluoride delivery and 
predicted efficacy highlight that FV deserve greater attention 
not only from the research community but also from 
legislative bodies. 
 In summary, the present laboratory study showed that 
commercially available fluoride varnishes vary greatly in 
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their predicted anticaries efficacy as evidenced by the 
differences in enamel fluoride uptake and the FV’s ability to 
reharden early caries lesions.  
a. Duraphat, Colgate Oral Pharmaceuticals, New York, NY., 
USAManufacturer, CITY, STATE, COUNTRY. 
b. FluorProtector, Ivoclar Vivadent, Schaan, LiechtensteinManufacturer, 
CITY, STATE, COUNTRY. 
c. Buehler, Lake Bluff, IL, USA. 
d. Struers Inc., Cleveland, OH, USA. 
e. Nikon, Tokyo, Japan. 
f. Wilson, Norwood, MA, USA. 
g. 3M ESPE Dental Products, St. Paul, MN, USA. 
h. Premier Dental Products Co., Plymouth Meeting, PA., USA. 
i. GC America Inc., Alsip, IL, USA. 
j. Colgate Oral Pharmaceuticals, Inc., New York, NY., USA. 
k. Precision Scientific Group, Chicago, IL, USA. 
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Table 1. Tested fluoride varnishes. 
__________________________________________________________________________________________________ 
 Name Noteworthy ingredients* 
__________________________________________________________________________________________________ 
 CavityShield Xylitol 
 Enamel Pro ACP 
 MI Varnish CPP-ACP 
 Prevident Xylitol 
 Vanish Tri-calcium phosphate, 
Xylitol 
__________________________________________________________________________________________________ 
* All FV claimed to contain 5% sodium fluoride. 
 
 
 
 
Table 2. Least square means ± standard error of the least square means and 
results of the statistical analyses for both study variables. 
__________________________________________________________________________________________________ 
 ΔKHN EFU 
 ___________________________________ _________________________________________ 
Varnish Indirect Direct Indirect Direct 
__________________________________________________________________________________________________ 
MI Varnish 146±9 a* 66±9 b* 6707±618 b* 3291±618 b* 
Enamel Pro 132±9 ab* 89±9 ab* 8858±660 a* 4590±660 ab* 
Prevident 124±9 abc 110±9 a 3320±618 c* 5116±618 a*  
CavityShield 110±9 bc 98±9 a 1801±618 c 3450±660 ab 
Vanish 103±9 c 103±9 a 2157±660 c 2838±660 b 
__________________________________________________________________________________________________ 
Different letters indicate statistically significant differences between groups, 
in columns (P< 0.05).  
* Statistically significant differences (P< 0.05) between application modes, 
for both ΔKHN and EFU. 
 
 
